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Abstract This study evaluated the morphology and immuno-
histochemistry of 85 canine cutaneous histiocytic tumours.
The tumours were classified morphologically as either canine
cutaneous histiocytomas (71 tumours) or canine cutaneous
histiocytic sarcomas (14 tumours). The immunohistochemical
analysis was conducted on paraffin sections using an antibody
panel (against MHCII, CD18, CD79αcy, CD3 and E-
cadherin). Histochemical staining with toluidine blue and
Gomori silver impregnation was also performed. A follow-
up was conducted via surveys. The histiocytic origin of the
tumour cells was confirmed in 65 of the canine cutaneous
histiocytomas and in 4 of the canine cutaneous histiocytic
sarcomas. The tumours that had been misdiagnosed as canine
cutaneous histiocytomas included plasmacytomas,
epitheliotropic T-cell lymphomas and undetermined entities.
The tumours misdiagnosed as canine cutaneous histiocytic
sarcomas included plasmacytomas and non-epitheliotropic
T-cell lymphomas, but the majority of them remained unde-
termined. The canine cutaneous histiocytomas showed
MHCII, CD18 and E-cadherin expression, but in several of
the tumours, the expression of CD18 or E-cadherin was con-
firmed in only a small percentage of the tumour cells. The
regressing canine cutaneous histiocytomas showed increased
T- and B-lymphocyte infiltration, a decreased mitotic index,
transport of the MHCII molecules from the cytoplasm to the
cell membrane and loss of E-cadherin expression in the
tumour cells. The canine cutaneous histiocytic sarcomas
showed both high morphological diversity and expression of
MHCII and CD18. Two of the evaluated histiocytic sarcomas
also showed expression of E-cadherin. In conclusion, immu-
nohistochemistry, including analysis ofMHCII, CD18 and the
lymphocytic markers CD3 and CD79, should be performed
for the diagnosis of canine cutaneous histiocytic tumours. The
expression of E-cadherin in canine cutaneous histiocytic sar-
comas suggests an origin of the tumour cells among
Langerhans cells.
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Introduction
Canine cutaneous histiocytoma (CCH) is a common benign
skin tumour of the dog, characterised by clonal proliferation of
Langerhans cells and showing expression of CD1 and specific
β2 integrins (Moore et al. 1996; Delcour et al. 2013). CCH
may have a similar morphologic appearance as other round
cell tumours; therefore, differentiation among CCH,
plasmacytomas, mast cell tumours and cutaneous lymphomas
based on histopathology alone is often challenging
(Fernandez et al. 2005). In CCH, intra-epidermal nests of
histiocytes are frequently noted, which resemble Pautrier’s
aggregates characteristic of epitheliotropic lymphoma (Moore
et al. 1996). Furthermore, the large number of lymphocytes in
regressing CCH make differentiation between CCH and non-
epitheliotropic lymphoma very difficult (Moore 2014). There-
fore, the diagnosis of CCH should be based on the
immunophenotype of the tumour cells. The most specific
marker for Langerhans cells is the CD1a molecule, which is
also expressed by the cortical thymocytes and dendritic cells
of the thymic medulla. Unfortunately, analysis of this marker
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requires snap-frozen tissue samples and cannot be used in
routine histopathology (Moore et al. 1996; Fernandez et al.
2005). The most reliable criteria for the immunohistochemical
diagnosis of CCH when only paraffin sections are available
are CD18 and MHCII positivity coupled with negative label-
ling for the lymphocytic markers CD3 and CD79α
(Fernandez et al. 2005). Furthermore, the expression of E-
cadherin is a valuable indicator of Langerhans cells’ differen-
tiation in CCH, but the true incidence of E-cadherin expres-
sion in CCH is not known (Moore 2014).
The unique feature of CCH is its spontaneous regression,
which occurs within 2–3 months (Schwens et al. 2011). The
factors determining the onset of CCH regression are unknown
(Moore et al. 1996). The spontaneous regression of the AK-5
histiocytoma in the rat is mediated by NK cells through
antibody-dependent cellular cytotoxicity, and target cell death
involves necrosis and apoptosis (Khar et al. 1997). The re-
gression of CCH is associated with infiltration by CD8
(cytotoxic) lymphocytes and increased expression of IL-2,
TNFα, IFNγ and iNOS mRNA (Kaim et al. 2006). CCH
regression is correlated with lymphocytic infiltration, trans-
port of MHCII molecules to the cell surface and loss of E-
cadherin expression (Cockerell and Slauson 1979; Kipar et al.
1998; Pires et al. 2009). The regression process primarily
involves T-lymphocytes, but a recent report also noted an
increase in B-lymphocytes in regressing CCH (Pires et al.
2013b). However, the incidence of granulocytes in relation
to the CCH regression was not evaluated.
Canine histiocytic sarcoma, which is derived from dendrit-
ic cells, occurs in a localised and disseminated form. Localised
histiocytic sarcoma is typically situated subcutaneously on the
limbs; other locations include the spleen, tongue, lung, brain
stem, nasal cavity, vertebral bone and epidural space. Dissem-
inated histiocytic sarcomas are most often found in the spleen,
liver, lung, bone marrow and lymph nodes (Affolter and
Moore 2002). Histiocytic sarcomas derived from splenic and
bone marrow macrophages are characterised by both tumour
cells with distinct haemophagocytic activity and an aggressive
clinical course (Moore et al. 2006). Cutaneous histiocytic
sarcomas most likely originate from the interstitial dermal
dendritic cells and show strong pleomorphism. It is typical
for large round cells, spindle cells and multinucleated giant
cells to be present within one tumour (Affolter and Moore
2002; Constantino-Casas et al. 2011). The spindle-cell-
predominant histiocytic sarcoma can mimic other pleomor-
phic sarcomas, whereas the round-cell-predominant histiocyt-
ic sarcoma should be differentiated from Langerhans cell
histiocytosis, poorly granulated mast cell tumours and
amelanotic melanomas (Lee Gross et al. 2005). Due to the
broad range of morphologic features observed in histiocytic
sarcomas, an immunophenotypic evaluation is necessary to
confirm the diagnosis (Affolter and Moore 2002). The tumour
cells of canine histiocytic sarcomas consistently express
CD18, MHCII, CD45, CD1 and CD11c but are lacking in
expression of E-cadherin (Lee Gross et al. 2005).
The first aim of the present study was to perform a detailed
evaluation of the morphology of and MHCII, CD18 and E-
cadherin immunoexpression in CCH and canine cutaneous
histiocytic sarcoma. The second aim of the study was to
evaluate changes in the immunophenotype of regressing
CCH and to assess the contribution of particular inflammatory
cell types to the spontaneous regression of CCH.
Materials and methods
Cutaneous tumours were collected from 85 dogs by surgical
excisional biopsies. All of the tissue samples were immedi-
ately fixed in 10 % buffered formalin, embedded in paraffin
wax, cut into 3 μm sections and mounted on silanised glass.
The sections were processed routinely and stained with
Mayer’s haematoxylin and eosin (HE). The tumours included
71 CCHs and 14 cutaneous histiocytic sarcomas. The tumours
were diagnosed on the basis of the histopathological exami-
nation according to widely used criteria (Lee Gross et al.
2005). The immunohistochemical examination of each tu-
mour was performed using an antibody panel (against
MHCII, CD18, CD79αcy, CD3, and E-cadherin) and a visu-
alisation system based on the immunoperoxidase method,
with 3,3-diaminobenzidine (DAB) as a substrate (Table 1).
The specimens were counterstained with Mayer ’s
haematoxylin, dehydrated and mounted using Canadian balm.
For the negative control, the primary antibody was either
replaced with mouse IgG2a (Dako, Glostrup, Denmark) at
the appropriate dilution (MHCII, CD18, CD79αcy, E-
cadherin) or omitted (CD3). For the positive control, normal
canine tonsil (MHCII, CD3, CD79αcy), canine cutaneous
purulent inflammation (CD18) and normal canine skin (E-
cadherin) sections were processed together with the evaluated
sections. The presence of mast cells was confirmed by tolui-
dine blue staining (Sigma-Aldrich, St. Louis, MO). Gomori’s
silver impregnation method for the reticulum was used to
detect reticulin fibres (staining kit, Bio-Optica, Milan, Italy).
Microscopic evaluation of the slides was conducted
using the Pannoramic MIDI scanner (3DHISTECH, Bu-
dapest, Hungary) and Pannoramic Viewer software
(3DHISTECH, Budapest, Hungary). The histiocytic origin
of the tumour cells was confirmed by immunohistochem-
istry (MHCII+, CD18+, CD79αcy-, CD3-) according to
Fernandez et al. (2005). A detailed morphological exam-
ination was performed using slides stained with HE. The
morphologic analysis included assessment of the density
of the cellular infiltration, the cellular and nuclear size
and shape, epithelial changes (ulceration, parakeratosis,
hydropic degeneration of keratinocytes, intra-epidermal
neoplastic infiltration), other changes (oedema, necrosis,
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angiogenesis) and the mitotic index. The mitotic index
was assessed by direct counting of the fraction of cell
nuclei in the ‘M’ phase of the cell cycle (Bacchi and
Gown 1993). The mitotic figures were evaluated on the
whole slide, and the mitotic index was defined as the
maximal number of mitotic figures per high-power field
(HPF) (magnification 400x). The inflammatory infiltrate
was evaluated on a scale of 1–4 points (1=single cells;
2=small foci of 3–9 cells; 3=large foci of more than 9
cells; 4=focal and diffuse) using slides stained with HE
(neutrophils, eosinophils), toluidine blue (mast cells),
CD3 immunohistochemical labelling (T-lymphocytes)
and CD79αcy immunohistochemical labelling (B-lym-
phocytes, plasma cells). Additionally, for CCHs, the pat-
tern of the lymphocytic infiltration was described as min-
imal, moderate, marked or massive, according to the clas-
sification of Cockerell and Slauson (1979). The expres-
sion of MHCII, CD18 and E-cadherin in the histiocytic
cells was evaluated quantitatively on a scale of 1–4 points
(1=less than 20 % positive histiocytic cells; 2=20–50 %
positive histiocytic cells; 3=51-80 % positive histiocytic
cells; 4=more than 80 % positive histiocytic cells). Addi-
tionally, the MHCII expression pattern was evaluated
qualitatively on a scale of 1–4 points (1=cytoplasmic
expression; 2=predominantly cytoplasmic expression;
3=predominantly membranous expression; 4=membra-
nous expression). Microphotographs were prepared using
a microscope equipped with a DP73 digital camera
(Olympus, Tokyo, Japan) and cellSens Dimension imag-
ing software (Olympus, Hamburg, Germany).
A follow-up was conducted by surveying the veterinarians
or owners. The survey included assessment of the incidence of
local recurrence and the survival time up to 2 years after the
diagnosis.
The results were analysed statistically. A Spearman
rank correlation analysis was used to detect the correla-
tions between the evaluated morphological and immuno-
histochemical features (r: Spearman rank correlation co-
efficient) of CCH. The number of histiocytic sarcomas
was too low to perform a reliable statistical analysis.
The correlations were considered statistically significant
when P<0.05. The statistical analysis was performed
using Statistica software (StatSoft 10 eng. 32 bit, Tulsa,
OK).
Results
The histiocytic origin of the tumour cells (MHCII+, CD18+,
CD79αcy-, CD3-) was confirmed in 65 CCHs and 4 cutane-
ous histiocytic sarcomas. Two tumours diagnosed histologi-
cally as CCH showed expression of CD3; therefore, their final
diagnosis was epitheliotropic T-cell lymphoma (Fig. 1a). Two
other tumours diagnosed histologically as CCH showed ex-
pression of CD79αcy; therefore, their final diagnosis was
plasmacytoma. In 2 of the cases of CCH, the origin of the
tumour cells remained undetermined, as they showed expres-
sion of MHCII but were negative for CD18, CD79αcy and
CD3. One tumour diagnosed histologically as a histiocytic
sarcoma showed expression of CD79αcy; therefore, its final
diagnosis was plasmacytoma. One other tumour diagnosed
histologically as a histiocytic sarcoma showed expression of
CD3; therefore, the final diagnosis was non-epitheliotropic T-
cell lymphoma (Fig. 1b). Eight tumours diagnosed histologi-
cally as histiocytic sarcomas remained undetermined after
immunohistochemistry (Fig. 1c and d). For all of the evaluated
tumours, the detailed immunophenotypes of the tumour cells
are summarised in Table 2.
Table 1 Primary antibodies, antigen retrieval and visualisation systems





1:20 2x3 min.b citrate buffer
pH 6
EnVision System-HRP, Mouse (DAB)a
CD18c monoclonal mouse anti-canine
CA16.3C10
1:10 5 min. proteinase Ka EnVision System-HRP, Mouse (DAB)a
CD3a polyclonal rabbit anti-human 1:50 2x3 min.b Tris-EDTA
buffer pH 9
ImmPRESS Universal Reagent Anti-Mouse/Rabbit
Ig Peroxidased
CD79αcya monoclonal mouse anti-human
HM57
1:25 4x3 min.b Tris-EDTA
buffer pH 9
EnVision System-HRP, Mouse (DAB)a
E-cadherina monoclonal mouse anti-human
NCH-38
1:50 2x3 min.b Tris-EDTA
buffer pH 9
EnVision System-HRP, Mouse (DAB)a
a Dako, Glostrup, Denmark
bAntigen retrieval was conducted in a microwave oven (650 W)
c PF. Moore, Davis, CA
dVector Laboratories Inc., Burlingame, CA
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CCH The tumours occurred exclusively as solitary cutaneous
nodules. The localisation of the tumours and the characteris-
tics of the affected dogs are summarised in Table 3. The
tumours were poorly circumscribed and nonencapsulated;
localised under the epidermis; and extending to the deep
dermis or, not uncommonly, to the subcutis. The neo-
plastic cells formed a solid mass with occasional sheet
formation. The cellular arrangement was superficially
loose and dense in the deeper areas of the tumour.
The neoplastic cells were round, oval or polygonal, with
abundant and slightly eosinophilic cytoplasm and indis-
tinct cell borders. The nuclei were round or reniform
and occasionally indented or folded. The chromatin was
finely dispersed (superficial areas of the tumour) or
Table 2 Histologic diagnosis and labelling panel results (final diagnosis) for evaluated canine cutaneous tumours
Histologic diagnosis No. Tumours MHCII CD18 CD79αcy CD3 E-cadherin Final diagnosis
CCH 65 + + - - + CCH
CCH 1 - - + - - plasmacytoma
CCH 1 + + + - + plasmacytoma
CCH 1 + + - + - epitheliotropic T-cell lymphoma
CCH 1 - - - + + epitheliotropic T-cell lymphoma
CCH 1 + - - - ND undetermined
CCH 1 + - - - - undetermined
histiocytic sarcoma 2 + + - - + HS
histiocytic sarcoma 2 + + - - - HS
histiocytic sarcoma 1 + + + - + plasmacytoma
histiocytic sarcoma 6 - - - - ND undetermined
histiocytic sarcoma 2 + - - - ND undetermined
histiocytic sarcoma 1 + - - + ND non-epitheliotropic T-cell lymphoma
Fig. 1 (a) Epitheliotropic T-cell lymphoma, dog. The tumour was
morphological ly diagnosed as CCH, reclass i f ied af ter
immunohistochemistry. The tumour cells expressed CD3 (inset). HE.
Inset: immunoperoxidase stain; DAB substrate; Mayer’s haematoxylin
counterstain. (b) Non-epitheliotropic T-cell lymphoma, dog. The tumour
was morphologically diagnosed as canine cutaneous histiocytic sarcoma,
reclassified after immunohistochemistry. The tumour cells expressed
CD3 (inset). HE. Inset: immunoperoxidase stain; DAB substrate;
Mayer’s haematoxylin counterstain. (c) Unclassified sarcoma, dog. The
tumour was morphologically classified as canine cutaneous histiocytic
sarcoma and was negative for MHCII, CD18, CD3 and CD79. HE. (d)
Unclassified sarcoma, dog. The tumour was morphologically classified as
canine cutaneous histiocytic sarcoma and was negative for MHCII,
CD18, CD3 and CD79. HE
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marginated (deep areas of the tumour), with single nu-
cleoli. The mitotic index was variable; most CCHs
showed 1–4 mitotic figures per HPF (magnification
400x), but single tumours showed up to 9 mitotic fig-
ures per HPF. The mitotic index was negatively corre-
lated with the intensity of the lymphocytic infiltration
(r=−0.259; P=0.037). Prominent necrotic foci were
found in 38 % of the cases, but necrosis or apoptosis
of single tumour cells was common and associated with
the lymphocytic infiltration. The epidermal changes in-
cluded ulceration (92 % of the cases), parakeratosis
(21 % of the cases), intra-epidermal aggregates of tu-
mour cells (19 % of the cases, Fig. 2a) and hydropic
degeneration (15 % of the cases). Numerous capillary
vessels (angiogenesis) within the tumour (primarily in
the subepidermal areas) were evident in 37 % of the
cases. Reticulin fibres surrounded the tumour cells in
variable amounts.
The T-lymphocyte infiltrate was predominantly focal and
diffuse (77 % of the cases, Fig. 2b). B-lymphocytes and
plasma cells predominantly formed large foci (46 % of the
cases) or occurred as single cells (35 % of the cases). The
lymphocytic infiltration was minimal in 13 CCHs (20 %),
moderate in 27 CCHs (42 %), marked in 17 CCHs (26 %)
and massive in 8 CCHs (12 %). The T- and B-lymphocytes
(with plasma cells) were positively correlated (r=0.342; P=
0.005). Neutrophils were mostly observed as small or large
foci and were commonly associated with epidermal ulceration
and necrotic foci within the tumour. Eosinophils were noted in
21 % of the cases, as either single cells or small foci. Mast
cells were confirmed in 28 % of the cases, mostly as small
foci, and were localised within the tumour or at the tumour
periphery. The mast cells within the tumour and at the tumour
periphery were positively correlated (r=0.697;P=0.000). The
number of mast cells within the tumour was negatively
correlated with the intensity of the lymphocytic infiltration
(r=−0.277; P=0.026).
A quantitative analysis of MHCII, CD18 and E-
cadherin expression is summarised in Table 4. Two pri-
mary MHCII expression patterns were observed in the
tumour cells: diffuse cytoplasmic, with distinct
juxtanuclear foci only occasionally observed, and mem-
branous (rim-like). In approximately half of the tumours,
both expression patterns were observed, but with different
proportions of cells showing either a cytoplasmic or a
membranous labelling pattern. MHCII expression was
cytoplasmic in 32 % of the CCHs (Fig. 2c), predominant-
ly cytoplasmic in 31 % of the CCHs, predominantly
membranous in 20 % of the CCHs and membranous in
17 % of the CCHs. The MHCII expression pattern was
positively correlated with the intensity of the lymphocytic
infiltration (r=0.574; P=0.000) and negatively correlated
with the number of mast cells within the tumour
(r=−0.453; P=0.000) and at the tumour periphery
(r=−0.293; P=0.018). The CD18 expression pattern was
either strictly membranous or membranous with slight
cytoplasmic accentuation. Strong variations between the
labelling intensities were noted. Strong expression was
confirmed in 11 % of the CCHs; moderate, in 67 % of
the CCHs; and weak, in 22 % of the CCHs. The number
of tumour cells expressing CD18 was positively correlat-
ed with the intensity of the CD18 expression (r=0.642;
P=0.000), the intensity of the lymphocytic infiltration (r=
0.303; P=0.014), the number of tumour cells expressing
MHCII (r=0.638; P=0.000) and the MHCII expression
pattern (r=0.284; P=0.022). The E-cadherin expression
pattern was membranous. The positive cells were usually
subepidermally situated, gradually losing E-cadherin ex-
pression in the deeper parts of the tumour (Fig. 2d). There
were single cases in which the E-cadherin expression was
Table 3 Clinical
characteristics of the
evaluated cases of CCH
Sex Male 50 % of cases
Female 50 % of cases
Localisation Head, neck 47 % of cases
Trunk 11 % of cases
Limbs 42 % of cases
Age Under 3 years old 69 % of cases
Over 3 years old 31 % of cases
Breed (>4 cases) Boxer, Yorkshire Terrier, mongrel
Breed (1–4 cases) Labrador Retriever, American Staffordshire Terrier,
Dachshund, German Shepherd, French
Bulldog, Beagle, Border Collie, Scenthound,
Schnauzer, Russian Terrier, West Highland White
Terrier, Shar-Pei, Cocker Spaniel, Fox Terrier,
Bordeaux Mastiff, Pinscher, Poodle, Bull Terrier,
Golden Retriever, Great Dane
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limited to a few scattered cells within the tumour. The E-
cadherin expression was negatively correlated with the
intensity of the lymphocytic infiltration (r=−0.263;
P=0.036).
Follow-up was available in 44 of the CCH cases.
Recurrence was noted in two cases, but a subsequent
histopathological examination was not performed. Two
dogs (a 10-year-old Boxer and a 10-year-old American
Staffordshire Terrier) died within one year after the
surgery, but the reason for death was not associated
with CCH. Necropsies were not performed.
Histiocytic sarcoma The first case of histiocytic sarcoma oc-
curred as a solitary cutaneous nodule situated in the area of the
elbow in an 11-month-old mongrel male. The tumour was
poorly circumscribed, nonencapsulated, localised under the
epidermis, and extending to the deep dermis. The neoplastic
cells formed a solid mass, obliterating the adnexa, with a
dense cellular arrangement and abundant reticulin fibres.
The neoplastic cells were round to polygonal and oval to
fusiform, with abundant, slightly eosinophilic cytoplasm and
indistinct cell borders. The nuclei were oval, round or reni-
form, with marginated chromatin and indistinct nucleoli. The
mitotic index was 16. The second case of histiocytic sarcoma
occurred as a solitary cutaneous nodule situated in the thigh
area in an 8-year-old Cane Corso male. The tumour was
poorly circumscribed and nonencapsulated, localised in the
dermis, and extending deeply into the subcutis and focally to
the epidermis. The neoplastic cells formed sheets and cords,
with a loose cellular arrangement and a moderate amount of
reticulin fibres. The neoplastic cells were polygonal and stel-
late, with short cytoplasmic projections. The neoplastic cells
had a tendency to coalesce (Fig. 3a). The abundant cytoplasm
was deeply eosinophilic. The nuclei were round to polygonal,
with marginated chromatin and large, distinct nucleoli. The
mitotic index was 3. The tumour was focally necrotic. The
third case of histiocytic sarcoma occurred as multiple cutane-
ous nodules in a 6-year-old Shar-Pei female. The tumour was
poorly circumscribed and nonencapsulated, localised under
the epidermis and extending deeply into the subcutis. The
neoplastic cells formed a diffuse mass with a dense or occa-
sionally loose cellular arrangement and a moderate amount of
Fig. 2 CCH, dog. (a) Intra-
epidermal nests of neoplastic cells
(arrows). HE. (b) Neoplastic
histiocytoma cells accompanied







stain; DAB substrate; Mayer’s
haematoxylin counterstain. (d)
Expression of E-cadherin in
tumour cells, with strong
expression in the subepidermal
area of the tumour that gradually
decreased in the deeper parts of
the tumour. Immunoperoxidase
stain; DAB substrate; Mayer’s
haematoxylin counterstain
Table 4 Quantitative analysis of
MHCII, CD18 and E-cadherin
expression in CCH




20-50% 51-80% More than
80 %
Number (percentage) of histiocytoma
cases
MHCII 1 (2 %) 2 (3 %) 8 (12 %) 54 (83 %)
CD18 6 (9 %) 3 (5 %) 17 (26 %) 39 (60 %)
E-cadherin 18 (28 %) 23 (35 %) 23 (35 %) 1 (2 %)
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reticulin fibres. The neoplastic cells were round to polygonal,
with variable amounts of slightly eosinophilic cytoplasm
(Fig. 3b). The neoplastic cells had a tendency to coalesce,
and multinucleated cells were noted occasionally. The nuclei
were round to polygonal, with coarse or densely packed
chromatin and indistinct single nucleoli. The mitotic index
was 12. The fourth case of histiocytic sarcoma occurred as a
solitary cutaneous nodule located in the abdominal area in a 7-
year-old Pointer female. The tumour was poorly
circumscribed and nonencapsulated and was localised in the
subcutis. The neoplastic cells formed a solid mass with a
dense cellular arrangement and abundant reticulin fibres.
The neoplastic cells were polygonal, with abundant, deeply
eosinophilic cytoplasm. The nuclei were elongated, with mar-
ginated chromatin and 1–2 nucleoli of variable sizes. The
mitotic index was 2. The tumour was focally necrotic.
In all cases, the tumour cells were accompanied by numer-
ous T-lymphocytes (focal and diffuse infiltrate) and less nu-
merous B-lymphocytes (focal infiltrate or single cells). Neu-
trophils formed large foci, mostly related to the necrotic areas.
Mast cells and eosinophils were observed sporadically. The
MHCII expression pattern was membranous or cytoplasmic
and confirmed in more than 80 % of the tumour cells (three
cases) or in 51-80 % of the tumour cells (one case). The CD18
expression pattern was membranous and confirmed in more
than 80 % of the tumour cells (two cases), in 51-80 % of the
tumour cells (one case) or in 20-50 % of the tumour cells (one
case). The tumour cells were E-cadherin positive in two cases.
The expression of E-cadherin was membranous (Fig. 3c;
confirmed in more than 80 % of the tumour cells) or mem-
branous and cytoplasmic (Fig. 3d; confirmed in 51–80 % of
the tumour cells).
In the first case of histiocytic sarcoma, the tumour recurred,
and the dog died within a year of the diagnosis. According to
the survey, the cause of death was related to the tumour, but
neither a histopathological examination of the recurrent tu-
mour nor necropsy was performed. In the second case, the
tumour recurred within a year of the diagnosis, and in the
following months, multiple nodules developed in the
neighbouring areas. One of the tumours was excised surgical-
ly, and a histopathological examination confirmed the histio-
cytic sarcoma. The dog was still alive at the time of the survey
(2 years after the initial diagnosis). In the third case, the dog
was euthanised due to a poor prognosis following the diagno-
sis. In the fourth case, the dog died within two years of the
diagnosis. According to the survey, the cause of death was
related to the tumour, but a necropsy was not performed.
Discussion
The present study revealed that a routine histopathological
examination based solely on morphology is insufficient for
diagnosing CCH. Six of the 71 tumours (8 %) that were
diagnosed as CCH had to be reclassified after an immunohis-
tochemical examination. The tumours misdiagnosed as CCH
included epitheliotropic lymphoma and plasmacytoma. Lee
Gross et al. revealed that CCH and cutaneous T-cell
Fig. 3 Canine cutaneous
histiocytic sarcoma, dog. (a)
Polygonal to stellate neoplastic
cells with short cytoplasmic
projections and a tendency to
coalesce. HE. (b) Round to
polygonal neoplastic cells with
variable amounts of slightly
eosinophilic cytoplasm and
frequent mitotic figures, often
bizarre (arrows). HE. (c) Tumour




counterstain. (d) Tumour cells
showing cytoplasmic
(arrowhead) and membranous
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lymphoma can mimic each other perfectly; thus, immunohis-
tochemistry is often required for differentiation (2005).
Plasmacytoma (or B-cell lymphoma) has also previously been
misdiagnosed as CCH (Fernandez et al. 2005). The other
differential diagnoses for CCHs include Merkel cell tumours,
amelanotic melanomas, poorly granulated mast cell tumours
and transmissible venereal tumours (Lee Gross et al. 2005).
Two of the 71 tumours (3 %) showed expression of MHCII
and were negative for the other evaluated antigens, therefore
remaining undetermined after the immunohistochemical ex-
amination. A possible diagnosis for these tumours is
plasmacytoma, as approximately 20% of plasmacytomas lack
CD79 expression (Moore et al. 2000).
The majority of the evaluated CCHs occurred in dogs
under 3 years of age and were situated in the areas of the
head, neck or limbs, which is consistent with previous reports
(Schwens et al. 2011; Moore 2014). The most affected breeds
included Boxers, Yorkshire Terriers and mongrels, but this
most likely reflects the breeds’ prevalence in society, rather
than a true breed predilection. However, the Boxer is regarded
(together with Dachshunds) as a predisposed breed (Moore
2014). Themorphology of CCH described in the present study
is consistent with previous reports (Taylor et al. 1969; Moore
et al. 1996; Lee Gross et al. 2005; Schwens et al. 2011; Moore
2014). However, the intra-epidermal aggregates of the tumour
cells were confirmed in only a small percentage of the cases in
the current study, whereas in previous studies, neoplastic
intra-epidermal aggregates were considered to be a frequent
feature of CCH (Moore et al. 1996; Lee Gross et al. 2005). In
our opinion, evaluation of the epidermis covering a CCH
could be problematic due to very frequent massive ulceration.
However, intra-epidermal invasion by tumour cells is most
likely not as prevalent as previously reported, which has also
been suggested by another author (Moore 2014). The other
epidermal changes described in the present study, such as
parakeratosis and hydropic degeneration, are commonly asso-
ciated with a response to chronic stimuli (McGavin and
Zachary 2012). In several of the cases of CCH in the present
study, the epidermal ulceration was accompanied by distinct
angiogenesis in the adjacent tumour mass. Such angiogenesis
is associated with inflammation and is stimulated by macro-
phages and dendritic cells (Dong et al. 2009). The mitotic
index of the evaluated CCHs was highly variable but typically
moderate. There were also tumours with surprisingly high
mitotic indexes. Previous reports have described the mitotic
activity in CCH as moderate (Lee Gross et al. 2005) or as
highly variable but often high (Moore 2014). CCH shows the
highest mitotic index compared with other benign cutaneous
tumours in dogs (Martin de Las Mulas et al. 1999). In the
present study, the mitotic index decreased with an increase in
the intensity of the lymphocytic infiltration. We suggest that
the infiltrating lymphocytes may contribute to the inhibition of
proliferation in CCH. The decrease in the mitotic index with
tumour regression was previously shown in CCH (Baines
et al. 2000) and in transmissible venereal tumours
(Mukaratirwa et al. 2006). However, no significant differences
in Ki67 expression at the different stages of CCH regression
have been shown (Pires et al. 2013a).
T-lymphocytes frequently accompany CCH tumour cells,
taking part in the immune-mediated spontaneous regression
(Cockerell and Slauson 1979). In the present study, T-
lymphocytes were numerous in most of the CCHs and defin-
itively outnumbered B-lymphocytes. As previously reported,
most of the lymphocytes infiltrating CCHs were CD3+ and
CD8+, whereas B-lymphocytes and CD4 lymphocytes were
encountered less frequently (Moore et al. 1996). The results of
the present study showed that the T- and B-lymphocytes were
positively correlated, which suggests a synergistic role for the
two lymphocytic populations in tumour regression. B-
lymphocytes are able to mediate tumour regression, which
has been shown in adoptive cancer immunotherapy (Li et al.
2009). Kipar et al. reported that the numbers of B-
lymphocytes and plasma cells increased slightly within focal
inflammatory infiltrates in CCH (1998). Pires et al. noted an
increase in both T- and B-lymphocytes in regressing CCHs
(2013b). In the present study, neutrophils were primarily
associated with the necrotic foci, but neither the number of
neutrophils nor the incidence of the necrotic foci was related
to the intensity of the lymphocytic infiltration. The mecha-
nism of tumour regression is connected with CD8+ lympho-
cytes, which cause the apoptosis or necrosis of tumour cells
(Barry and Bleackley 2002). However, a previous study re-
ported that the apoptotic rate was not increased in regressing
histiocytomas, most likely due to the rapid turnover of the
apoptotic cells in the tissue (Kaim et al. 2006). In the present
study, eosinophils were found only incidentally, which is
consistent with previous reports (Lee Gross et al. 2005).
Furthermore, mast cells were noted in only several of the
CCHs, and the number of mast cells decreased with the
intensity of the lymphocytic infiltration. In transmissible ve-
nereal tumours, there are higher mast cell counts within
regressing tumours than within progressing tumours
(Mukaratirwa et al. 2006). T cell-derived mediators, such as
the beta-chemokines, directly induce mast cell degranulation
(Mekori and Metcalfe 1999). Degranulated mast cells are not
recognisable with toluidine blue, which may explain why
these cells were found to be prevalent in the CCHs with
minimal or moderate lymphocytic infiltration. To evaluate
the true incidence of mast cells in CCH, specific markers
should be used, such as mast cell tryptase.
The great majority of evaluated CCHs showed expression
of MHCII in nearly all of the tumour cells. MHCII, together
with CD18, is considered to be a reliable marker for the
leukocytic origin of tumour cells (Fernandez et al. 2005).
However, 17 % of the cases showed MHCII expression in
only some of the tumour cells, which has also been noted by
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other authors (Kipar et al. 1998). The MHCII labelling pattern
in CCH tumour cells was previously detected as focal
juxtanuclear cytoplasmic labelling and/or rim-like labelling
along the cell periphery (Kipar et al. 1998; Pires et al.
2013b). In the present study, mixed labelling patterns were
additionally observed, as approximately half of the evaluated
tumours consisted of a mixed tumour cell population showing
an either cytoplasmic or membranous labelling pattern. The
transport of the MHCII molecules from the cytoplasmic ves-
icles to the cell membrane reflects the maturation process of
dendritic cells after antigenic stimulation (Van Niel et al.
2008) and appears to be crucial for the onset of CCH regres-
sion (Kipar et al. 1998). In the present study, the MHCII
expression pattern was positively correlated with the intensity
of the lymphocytic infiltration, which supports previous ob-
servations (Kipar et al. 1998; Pires et al. Pires et al. 2013b).
The presentation of a yet-unknown antigen together with
MHCII might induce the priming and activation of T-cells
and the development of tumour-specific cytotoxic T-cells
(Kipar et al. 1998), suggesting that CCH is a self-limiting
neoplastic disease in which tumour cells cause immune-
mediated self-destruction.
The present study demonstrated that the number of
tumour cells showing CD18 expression was positively
correlated with the intensity of the expression and that a
significant number of CCHs showed CD18 expression in
only a small number of the tumour cells. A reasonable
explanation for this level of expression may be a loss of
antigenicity due to prolonged fixation (Haines and
Chelack 1991). Meanwhile, the positive correlation be-
tween MHCII and CD18 expression in tumour cells sug-
gests that less differentiated tumour cells can be negative
for the markers characteristic of their cell line. The results
of this study showed that the number of tumour cells
expressing CD18 was positively correlated with the inten-
sity of the lymphocytic infiltration, indicating that well-
differentiated tumour cells are more prone to regression.
E-cadherin is expressed by both normal Langerhans cells
and CCH tumour cells (Jakob et al. 1999; Baines et al. 2008).
Although E-cadherin is regarded as a constant feature of the
CCH immunophenotype, CCHs lacking E-cadherin expres-
sion have also been observed (Moore 2014). In the present
study, most tumours showed E-cadherin expression in some of
the tumour cells, and in single cases, there were only few E-
cadherin-positive cells. In these cases, the E-cadherin expres-
sion could be easily overlooked. Therefore, the expression of
E-cadherin is of limited diagnostic value in CCH. According
to Valli et al., Langerhans cells are the only leukocytes that
express E-cadherin (2002). However, in the present study, one
of the misdiagnosed plasmacytomas and one epitheliotropic
lymphoma showed E-cadherin expression. Therefore, E-
cadherin expression is not specific to Langerhans cells and
cannot distinguish canine cutaneous round cell tumours,
which was also confirmed in a previous study (Ramos-Vara
and Miller 2011). The present study revealed that E-cadherin
expression decreased with an increase in the intensity of the
lymphocytic infiltration. The decrease in E-cadherin expres-
sion in normal Langerhans cells is connected with the cells’
migration to the lymph nodes and reflects their maturation
after antigenic stimulation (Wang et al. 1999; Baines et al.
2008). Therefore, the CCH tumour cells most likely undergo a
maturation process in a similar manner as normal Langerhans
cells do, which is also supported by other authors (Baines et al.
2000; Pires et al. 2009). The loss of E-cadherin expression in
CCH suggests that the tumour cells of regressing tumours can
migrate to the draining lymph nodes. Little is known about the
migration of CCH tumour cells to the draining lymph nodes,
and the true incidence is most likely underestimated (Moore
et al. 1996).
CCH is a benign tumour, and the recurrence rate is ex-
tremely low (Moore 2014). In the present study, 2 of the 44
CCHs with available follow-up information (5 %) recurred
after surgical excision, so although the recurrence rate is low,
it should not be regarded as incidental. However, the lack of
histopathological examinations of the recurrent tumours limits
the interpretation of this finding.
The present study revealed that immunohistochemistry is
absolutely required in diagnosing canine cutaneous histiocytic
sarcomas. Ten of the 14 tumours (71 %) diagnosed as histio-
cytic sarcomas had to be reclassified after the immunohisto-
chemical examination, and most of them remained undeter-
mined, as they were negative for all or nearly all of the
evaluated markers. The reason for the high rate of misdiagno-
ses may be either the poorly specified diagnostic criteria or
strong morphological variations in this group of cutaneous
tumours. Canine histiocytic sarcomas can mimic other spindle
cell or round cell sarcomas; therefore, immunophenotypic
evaluation is required (Affolter and Moore 2002). In the
current study, the tumours misdiagnosed as histiocytic sarco-
mas included, other than the undetermined tumours, non-
epitheliotropic lymphoma and plasmacytoma. In contrast to
non-epitheliotropic lymphoma, plasmacytoma has been in-
cluded in the differential diagnoses of round-cell-
predominant histiocytic sarcomas by certain authors (Lee
Gross et al. 2005). Undetermined tumours should be subjected
to further immunohistochemistry, such as analysis of smooth-
muscle actin, desmin, vimentin, von Willebrand factor or
neuron-specific enolase, before a final diagnosis of “poorly
differentiated sarcoma” should be made.
The small number of cutaneous histiocytic sarcomas that
were evaluated does not allow any generalisations or conclu-
sions to be made about their incidence, their breed or sex
prevalence, or their preferred locations. However, the difficul-
ty in collecting more tumour samples indicates that these
tumours are rare, especially compared with their benign coun-
terpart, or are frequently misdiagnosed and therefore
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underestimated. Furthermore, the histiocytic sarcomas de-
scribed in this report showed marked morphological diversity.
The cellular shape varied from round or polygonal to fusi-
form. None of the described tumours was characterised by the
presence of all three cellular populations of round, spindle and
multinucleated giant cells, as described previously (Affolter
and Moore 2002). Regarding the shape of the predominating
cells, a spindle-cell-predominant and round-cell-predominant
pattern of histiocytic sarcoma was previously distinguished
(Lee Gross et al. 2005). In Flat-Coated Retrievers, the histio-
cytic subtype and histiocytic-spindle-pleomorphic subtype
have been described (Constantino-Casas et al. 2011). The
evaluated histiocytic sarcomas showed pleocellular or pre-
dominantly lymphocytic inflammatory infiltrates. Histiocytic
sarcomas tend to have more cellular variability in the accom-
panying inflammatory cells compared with other soft tissue
sarcomas (Valli et al. 2002). In the present study, the histio-
cytic sarcomas showed MHCII and CD18 expression, as
previously described (Affolter and Moore 2002;
Constantino-Casas et al. 2011). However, two of the evaluated
histiocytic sarcomas were also E-cadherin positive. E-
cadherin is a lineage-associated marker for Langerhans cells
(Moore 2014). The cutaneous histiocytic sarcoma is derived
from interstitial dendritic cells and therefore lacks expression
of E-cadherin (Lee Gross et al. 2005). Ramos-Vara and Miller
described E-cadherin expression in five cutaneous histiocytic
sarcomas, but without immunohistochemical confirmation of
the histiocytic origin of the tumour cells (2011). The results of
the present study suggest that cutaneous histiocytic sarcomas
may possibly be derived not only from interstitial dendritic
cells but also from Langerhans cells.
In conclusion, a routine histopathological examination
is insufficient for diagnosing CCHs and canine cutane-
ous histiocytic sarcomas. Immunohistochemistry, includ-
ing analysis of MHCII, CD18 and the lymphocytic
markers CD3 and CD79, should be performed in ques-
tionable cases of CCH and in any case of canine cuta-
neous histiocytic sarcoma. E-cadherin expression is of
limited diagnostic value in CCH. Certain canine cutane-
ous histiocytic sarcomas are E-cadherin positive and are
therefore possibly derived from Langerhans cells. The
spontaneous regression of CCH, determined by T- and
B-lymphocyte infiltration, is connected with a decrease
in the mitotic index, an increase in the transport of
MHCII molecules from the cytoplasm to the cell mem-
brane, and a loss of E-cadherin expression in the tu-
mour cells. The present study highlights the practical
aspects of diagnosing canine cutaneous histiocytic
tumours.
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